No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
GSK’s Nucala® (Mepolizumab) FDA Approved for COPD
On 2 June 2025, Sandoz announced its US launch of Wyost® and Jubbonti®, biosimilars to Amgen’s Xgeva® and Prolia® (denosumab), respectively. Wyost® and Jubbonti® are the first and only…